KROS
Keros Therapeutics Inc.
$21.51
-$0.18(-0.83%)
59
Overall
60
Value
75
Tech
42
Quality
Market Cap
$500.56M
Volume
367.42K
52W Range
$9.12 - $72.37
Target Price
$23.38
EPS Estimates Overview
| Current Quarter | $-0.49 | Next Quarter | $-0.55 |
| Current Year | $2.25 | Next Year | $-3.47 |
| QoQ Growth | -12.2% | YoY Growth | -254.2% |
| 3Y EPS CAGR | -25.7% | Target Price | $23.38 |
| Consensus | Buy | Upside | +8.7% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | KROS | $21.51 | -0.8% | 367.42K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |